Viewing data from:

ZIPRASIDONE MESYLATE

ANDA

ZIPRASIDONE MESYLATE | A211908 | GLAND PHARMA LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: GEODON(TE code: AP)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$21.81

per ea

Lowest NADAC/Unit

$21.81

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
43598006158ZIPRASIDONE 20 MG/ML VIAL	$21.81	EA	Generic	—	2026-06-17
72266016042ZIPRASIDONE 20 MG/ML VIAL	$21.81	EA	Generic	—	2026-06-17
72266016010ZIPRASIDONE 20 MG/ML VIAL	$21.81	EA	Generic	—	2026-06-17
43598084858ZIPRASIDONE 20 MG/ML VIAL	$21.81	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain3 active DMFs

3 active API suppliers hold Drug Master Files for this ingredient.

MSN LIFE SCIENCES PRIVATE LTDZIPRASIDONE MESYLATE TRIHYDRATE

DMF 347152020

SUN PHARMACEUTICAL INDUSTRIES LTDZIPRASIDONE MESYLATE TRIHYDRATE

DMF 377592023

APITORIA PHARMA PRIVATE LTDZIPRASIDONE MESYLATE TRIHYDRATE

DMF 387452023

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Mar 17, 2020	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 20MG BASE/VIAL

0 patents0 exclusivities▴

POWDER;INTRAMUSCULAR | Approved: Dec 26, 2019

No patent or exclusivity listings for this strength.